DSpace Repository

CD320 as a potential clinical biomarker for GOF p53 mutants in non-small cell lung cancer

Files in this item

The following license files are associated with this item:

This item appears in the following Collection(s)

Attribution-NonCommercial-NoDerivs 3.0 United States Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States